Thrombectomy devices market seen reaching $2.48 billion by 2030

The thrombectomy devices market is projected to rise from $1.64 billion in 2025 to $1.78 billion in 2026, with growth driven by more ischemic stroke cases, expanding stroke centers and broader training. The Business Research Company expects North America to lead in 2025, while Asia-Pacific grows fastest through 2030.

Why it matters: - Thrombectomy devices are tied directly to acute ischemic stroke care, where faster clot removal can restore blood flow and improve outcomes. - Growth in the market signals rising demand for minimally invasive neurovascular treatment as stroke burden increases worldwide. - An aging global population is expected to keep expanding the pool of patients with stroke, coronary artery disease, aortic thrombosis and deep vein thrombosis.

What happened: - The Business Research Company released its Thrombectomy Devices Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report estimates the thrombectomy devices market will grow from $1.64 billion in 2025 to $1.78 billion in 2026. - The report projects the market will reach $2.48 billion by 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will post the fastest growth rate during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company published the release from London on August 31, 2026.

The details: - The 2026 to 2035 forecast implies an 8.3% CAGR from 2025 to 2026 and an 8.7% CAGR through 2030. - The report links near-term growth to more ischemic stroke cases, better access to specialized stroke centers, advances in catheter-based intervention methods, greater clinician awareness and more neurointerventional training programs. - Long-term growth is expected from broader use of thrombectomy across more patient groups, faster reperfusion goals, stronger neurovascular infrastructure, investment in next-generation devices and more combination therapies. - Emerging trends include wider use of aspiration-based thrombectomy, greater reliance on stent retriever devices, rapid stroke intervention protocols, more minimally invasive neurovascular treatments and better device precision and maneuverability. - Thrombectomy devices use vacuum aspiration or catheter-based removal tools to extract clots during acute ischemic stroke treatment. - The company offers a free sample report and a full report online through the sample report and the full report.

Between the lines: - The market outlook reflects a combination of clinical need and infrastructure expansion, not just device innovation. - WHO demographic data cited in the release points to a stronger long-term tailwind, with one in six people globally expected to be 60 or older by 2030 and the 60-plus population projected to reach 2.1 billion by 2050. - Asia-Pacific’s growth outlook suggests room for adoption gains in markets still building stroke-treatment capacity.

What's next: - Market competition is likely to focus on aspiration systems, stent retrievers and devices that shorten time to reperfusion. - Expanded stroke-center networks and neurointerventional training should continue supporting adoption. - The company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspot infographics and updated graphics and tables.

The bottom line: - Thrombectomy devices are moving from a specialized stroke tool to a broader growth market, with aging populations and better stroke infrastructure driving the next phase of expansion.